China National Biopharmaceutical Group

Sinopharm, officially known as China National Pharmaceutical Group Co., Ltd., is a leading state-owned healthcare enterprise and the largest pharmaceutical company in China. The group operates across the entire industry value chain, encompassing research and development, manufacturing, logistics, and retail of pharmaceutical and healthcare products. It gained significant global recognition for its development of inactivated COVID-19 vaccines through its subsidiary, China National Biotec Group (CNBG). Beyond vaccines, Sinopharm is a major provider of small molecule drugs, biologics, and medical devices, serving both domestic and international markets. The company manages several publicly traded subsidiaries and maintains a vast distribution network that forms the backbone of China's medicine supply chain.